(Q40744502)

English

Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels

scientific article published on March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels (English)

1 reference

Europe PubMed Central

23 September 2017

1 reference

based on heuristic

inferred from title

metastatic melanoma

1 reference

based on heuristic

inferred from title

Bernard Escudier

8

object named as

Bernard Escudier

1 reference

Europe PubMed Central

23 September 2017

Pierre-Yves Dietrich

12

object named as

Pierre-Yves Dietrich

1 reference

Europe PubMed Central

23 September 2017

4

object named as

Franco Cavalli

1 reference

Europe PubMed Central

23 September 2017

Reinhard Dummer

13

object named as

Reinhard Dummer

1 reference

Europe PubMed Central

23 September 2017

author name string

Christoph Rochlitz

1

1 reference

Europe PubMed Central

23 September 2017

Brigitte Dreno

2

1 reference

Europe PubMed Central

23 September 2017

Peter Jantscheff

3

1 reference

Europe PubMed Central

23 September 2017

Patrick Squiban

5

1 reference

Europe PubMed Central

23 September 2017

Bruce Acres

6

1 reference

Europe PubMed Central

23 September 2017

Martine Baudin

7

1 reference

Europe PubMed Central

23 September 2017

Lucie Heinzerling

9

1 reference

Europe PubMed Central

23 September 2017

Rudolf Morant

10

1 reference

Europe PubMed Central

23 September 2017

Richard Herrmann

11

1 reference

Europe PubMed Central

23 September 2017

publication date

1 March 2002

1 reference

Europe PubMed Central

23 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

23 September 2017

9

1 reference

Europe PubMed Central

23 September 2017

3

1 reference

Europe PubMed Central

23 September 2017

289-295

1 reference

Europe PubMed Central

23 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700441

0 references

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Immunological gene therapy with ex vivo gene-modified tumor cells: a critique and a reappraisal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Inhibition of tumor growth by histoincompatible cells expressing interleukin-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Gene therapy of malignant gliomas: a phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

IL-12 gene therapy for cancer: in synergy with other immunotherapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Cancer vaccines: the interleukin 2 dosage effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Cytokine therapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

21 January 2018

Immune response against tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

7 January 2021

based on heuristic

inferred from DOI database lookup

Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700441

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700441

1 reference

Europe PubMed Central

23 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40744502&oldid=2101535538"